Djibouti vs Mauritania: Share of pregnant women with HIV that receive antiretroviral therapy
Djibouti
38.0%
in 2024
Mauritania
39.0%
in 2024
Djibouti rank
74th
Mauritania rank
73rd
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Djibouti
- Mauritania
How they compare
Mauritania currently reports 39.0% against 38.0% in Djibouti, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Djibouti ranks 74th and Mauritania ranks 73rd of 84 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.4% | 2.0% | 4.4% | Djibouti |
| 2010s | 28.2% | 25.1% | 3.1% | Djibouti |
| 2020s | 34.0% | 28.4% | 5.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Djibouti or Mauritania?
- Mauritania, at 39.0% against 38.0% in Djibouti as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Djibouti and Mauritania?
- 1.0%, with Mauritania ahead.
- How many years of comparable data are there for Djibouti and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Djibouti and Mauritania rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Djibouti ranks 74th and Mauritania ranks 73rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.